PEDIATRICS Vol. 106 No. 4 Supplement October 2000, pp. 897-898
From the Department of Pediatrics, Boston University School of Medicine/Boston Medical Center, Boston, Massachusetts.
In this issue of the Journal, Finkelstein
and colleagues1 have outlined the failure of pediatricians
and family practitioners to adhere to many of the recommendations of
the National Institutes of Health (NIH) asthma guideline.2
Although more detailed than previous reports, this study is consistent with a number of others that have documented inconsistencies between physician practice and the NIH asthma guideline.3,4 Where
do we stand with respect to clinical and health services research and
asthma in children? There are a number of important questions that
remain unanswered.
The diagnosis of asthma in children <2 to 3 years old can be
complicated and elusive. Unfortunately, the NIH asthma guideline is not
helpful with respect to making the diagnosis in young
children.2 The majority of diagnostic criteria are only
relevant for older children, adolescents, and adults. If an
18-month-old child wheezes twice, 6 months apart, does he or she have
asthma? Does the diagnosis change if there is a family history of
asthma and the child has atopy? Ensuring appropriate therapy for asthma
is obviously dependent on a secure diagnosis. It is not yet clear how
we make the diagnosis of asthma in young children.
The NIH guideline is predicated on diagnosing asthma accurately and
then categorizing the patient appropriately with respect to severity.
The most important groups to distinguish between are those with
intermittent and persistent disease. The NIH guideline is quite clear
in recommending antiinflammatory therapies for children with persistent
disease. Nevertheless, correctly categorizing children using
traditional health services databases (number of hospitalizations,
number of emergency department visits, pharmacy fills) is inadequate.
Categorization is dependent on knowing how often children have symptoms
of disease, not health care utilization resulting from those symptoms.
Health care utilization reflects many issues, including
parent perception of disease, access to care, and adherence
to appropriate therapy. In addition, correctly categorizing children
who wheeze intermittently is quite complicated. Many of the children we
care for wheeze periodically during the winter months, but then rarely
during the spring and summer. It is unclear what category these
children should be placed in and if antiinflammatory therapy is
indicated. We need more research in delineating how to categorize young
children accurately.
We believe that more young children with asthma are being placed on
antiinflammatory medications, particularly inhaled steroids. This is in
response to the NIH guidelines and recommendations of many asthma
experts. The data indicating that the long-term use of inhaled steroids
is safe are quite limited.5 Certainly inhaled steroids are
safer and have less complications than the regular use of oral
steroids, but little information is known about morbidity associated
with use over 5 to 10 years. We are particularly concerned that there
may be differences between types of inhaled steroids, and that their
impact may be different based on gender.6 The impact on
females may be far more serious then males, particularly because
osteoporosis is gender-specific. Although inhaled steroids are a key
component of asthma therapy, it is critically important that additional
data are collected about long-term consequences.
Ultimately, the most important aspect of asthma research from a
clinical standpoint is to find creative approaches to improving quality
of care, and impact on both health processes and outcomes. We were
encouraged by a recent report that suggested that clinicians in
practice, attending an interactive seminar based on the theory of
self-regulation, improved how they treat children with
asthma.7 At the recent Pediatric Academic Societies (PAS)
meeting, there was an additional report about the positive effect of
practice-based continuous quality improvement techniques on processes
of care.8 It will be far easier to improve the quality of
inpatient asthma care than ambulatory care. During hospitalization, it
is possible to improve quality using either clinical paths or physician
order entry with specific computer prompts. These techniques are
generally not available in the outpatient setting, and the approaches
to improving quality of care will have to be far more creative.
Although disease management techniques may be successful, the majority of children with asthma are not going to be cared for in specialty programs.9
Although the NIH report is usually referred to as a guideline, it
should be more accurately described as a mixture of guideline and
consensus statement. A number of the key recommendations of the report,
although based on a comprehensive review of the medical literature,
really reflect a combination of data and wisdom, because there is
limited information on which to base some of the recommendations. For
example, the report recommends that certain patients be referred for
specialty care. Although it would be hard to argue with referring a
child with a life-threatening asthma event, the other criteria for
referral are not evidence-based, but rather consensus-based. Unfortunately, in the report, there is no "strength of evidence" statements about the various recommendations.10 Physicians
have indicated that they are more likely to follow guidelines if they
are based on evidence, rather than consensus.11,12 In the
next rendition of the NIH asthma guideline, it would be helpful if
"strength of evidence" followed each recommendation.
Finkelstein and colleagues surveyed pediatricians and family
practitioners. Although there are always concerns if physician responses in surveys reflect actual care, the study is strengthened by
the inclusion of clinical vignettes. There was recently a report indicating that responses to clinical vignettes may be as accurate as
standardized patients and abstraction of medical records in measuring
quality of care.13 The Finkelstein study also indicates
that there are differences between how pediatricians and family
practitioners behave with respect to caring for children with asthma.
These results are not surprising. There was a recent report that found
that pediatricians and family practitioners deal with consensus
statements and guidelines related to oral antibiotic use
differently.14 The approach to changing physician behavior
may have to reflect the specialty of the target physicians.
At the recent PAS meeting there were numerous reports of physician
failure to adhere to the NIH asthma guidelines. At this point, we no
longer need to describe our failures to comply with these
recommendations. We need to answer some of the important and far more
complicated questions, such as: when should a young child with
recurrent wheeze be labeled asthmatic; which children should be
referred for specialty care; are there any early therapies that will
prevent long-term morbidity of asthma; how does housing impact on
asthma morbidity and can we effectively intervene; and how do we change
physician behavior, either at the individual or organizational level,
and improve the health outcomes of children. Our talented clinical and
health services research community needs to focus on answering these
important questions.
![]()
ARTICLE
Top
Article
References
Address correspondence to Howard Bauchner, MD, 91 E Concord St, Boston Medical Center/Maternity 415, Boston, MA 02118. E-mail: howard.bauchner{at}bmc.org
| |
ABBREVIATIONS |
|---|
NIH, National Institutes of Health; PAS, Pediatric Academic Societies.
| |
REFERENCES |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||